The in-vitro antibiotic susceptibility of Chlamydia pneumoniae
- 1 December 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 26 (6) , 763-767
- https://doi.org/10.1093/jac/26.6.763
Abstract
A cell culture technique was used to test the in-vitro susceptibility of the type strain of Chiamydia pneumoniae to 23 antibiotics including macrolides, tetracyclines and quinolones. The activity of the antibiotics tested was similar to previous findings with C. trachomatis. Clarythromycin had the lowest MIC overall (0·007 mg/l). Other macrolides were found to have similar MICs to erythromycin (0·06 mg/l). Both the macrolides and the tetracyclines were more active than the quinolones. It is proposed that the tetracyclines and erythromycin should be the drugs of choice for treating infections with C. pneumoniae; however several other antibiotics need to be evaluated.Keywords
This publication has 4 references indexed in Scilit:
- In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR)Antimicrobial Agents and Chemotherapy, 1989
- In vitro drug susceptibility of Chlamydia sp. strain TWARAntimicrobial Agents and Chemotherapy, 1988
- A NewChlamydia psittaciStrain, TWAR, Isolated in Acute Respiratory Tract InfectionsNew England Journal of Medicine, 1986
- A comparison of the in-vitro activity of antimicrobials against Chlamydia trachomatis examined by Giemsa and a fluorescent antibody stainJournal of Antimicrobial Chemotherapy, 1985